Genmab A/S Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIS ALLAN GRAY LTD | 11/14/2025 | 11.08 M | $339.76 M | 39.87% | 1.79% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 10.95 M | $335.96 M | 2.73% | 1.77% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 3.82 M | $117.06 M | 100.00% | 0.62% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 3.64 M | $111.74 M | 5.46% | 0.59% |
| HARDING LOEVNER LP | 11/14/2025 | 3.48 M | $106.86 M | 19.19% | 0.56% |
| BLACKROCK, INC. | 11/12/2025 | 3.45 M | $105.83 M | 8.99% | 0.56% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.82 M | $86.54 M | 1.98% | 0.46% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 1.69 M | $51.75 M | -4.68% | 0.27% |
| MORGAN STANLEY | 11/14/2025 | 1.67 M | $51.36 M | -37.91% | 0.27% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 1.43 M | $43.94 M | -21.32% | 0.23% |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 1.41 M | $43.33 M | -19.02% | 0.23% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 1.39 M | $42.67 M | -14.05% | 0.23% |
| FMR LLC | 11/13/2025 | 1.12 M | $34.34 M | 64.53% | 0.18% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.12 M | $34.31 M | 25.79% | 0.18% |
| NORTHERN TRUST CORP | 11/14/2025 | 882.30 K | $27.06 M | 9.79% | 0.14% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 822.74 K | $25.23 M | -11.92% | 0.13% |
| ENVESTNET ASSET MANAGEMENT INC | 11/05/2025 | 809.94 K | $24.84 M | 8.05% | 0.13% |
| MARSHALL WACE, LLP | 11/13/2025 | 533.21 K | $16.35 M | -72.04% | 0.09% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 481.27 K | $14.76 M | 100.00% | 0.08% |
| WOODLINE PARTNERS LP | 11/14/2025 | 459.18 K | $14.08 M | -6.96% | 0.07% |
| FEDERATED HERMES, INC. | 11/03/2025 | 422.94 K | $12.97 M | 100.00% | 0.07% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 372.05 K | $11.41 M | 20.63% | 0.06% |
| LPL FINANCIAL LLC | 11/12/2025 | 371.26 K | $11.39 M | 48.01% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 328.09 K | $10.06 M | -42.22% | 0.05% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 11/06/2025 | 315.86 K | $9.69 M | 24.09% | 0.05% |
| CIBC WORLD MARKET INC. | 11/06/2025 | 279.93 K | $8.59 M | 100.00% | 0.05% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 265.00 K | $8.13 M | -11.67% | 0.04% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2025 | 248.10 K | $7.61 M | -61.83% | 0.04% |
| EAGLE GLOBAL ADVISORS LLC | 10/28/2025 | 244.47 K | $7.50 M | 16.25% | 0.04% |
| QUANTINNO CAPITAL MANAGEMENT LP | 11/14/2025 | 209.84 K | $6.44 M | 32.70% | 0.03% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 200.00 K | $6.13 M | 0.00% | 0.03% |
| NATIXIS ADVISORS, L.P. | 11/13/2025 | 193.95 K | $5.95 M | 48.68% | 0.03% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 175.00 K | $53.02 M | 100.00% | 0.03% |
| FOLKETRYGDFONDET | 11/03/2025 | 174.81 K | $5.36 M | 1.16% | 0.03% |
| AIMZ INVESTMENT ADVISORS, LLC | 11/12/2025 | 164.51 K | $5.05 M | -0.83% | 0.03% |
| CAPITAL FUND MANAGEMENT S.A. | 11/13/2025 | 161.68 K | $4.96 M | -28.65% | 0.03% |
| PRIVATE WEALTH ADVISORS, LLC | 12/01/2025 | 135.09 K | $4.14 M | -8.93% | 0.02% |
| NEOS INVESTMENT MANAGEMENT LLC | 11/07/2025 | 132.04 K | $4.05 M | 1.40% | 0.02% |
| TEMA ETFS LLC | 10/24/2025 | 132.04 K | $4.05 M | 1.40% | 0.02% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 130.82 K | $4.01 M | -86.22% | 0.02% |
| JPMORGAN CHASE & CO | 11/26/2025 | 118.18 K | $3.62 M | -87.34% | 0.02% |
| ROYAL BANK OF CANADA | 11/14/2025 | 116.09 K | $3.56 M | -1.02% | 0.02% |
| CREATIVE PLANNING | 11/14/2025 | 115.85 K | $3.55 M | 77.87% | 0.02% |
| US BANCORP \DE\ | 11/12/2025 | 113.85 K | $3.49 M | 29.14% | 0.02% |
| POINT72 EUROPE (LONDON) LLP | 11/14/2025 | 107.86 K | $3.31 M | -77.13% | 0.02% |
| INGALLS & SNYDER LLC | 11/07/2025 | 107.27 K | $3.29 M | -10.22% | 0.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 101.18 K | $3.10 M | 32.28% | 0.02% |
| CITIGROUP INC | 11/10/2025 | 98.82 K | $3.03 M | 12.97% | 0.02% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 90.91 K | $2.79 M | -76.47% | 0.01% |
| UBS GROUP AG | 11/13/2025 | 82.17 K | $2.52 M | -83.05% | 0.01% |
Genmab A/S institutional Ownership - FAQ's
During the previous two years, 329 institutional investors and hedge funds held shares of Genmab A/S. The most heavily invested institutionals were:
Orbis Allan Gray Ltd: 11.08 M
ALLIANCEBERNSTEIN L.P.: 10.95 M
Paradigm Biocapital Advisors LP: 3.82 M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 3.64 M
HARDING LOEVNER LP: 3.48 M
BlackRock, Inc.: 3.45 M
10.00% of Genmab A/S stock is owned by institutional investors.
Institutional investors have bought a total of 72.91 M shares in the last 24 months. This purchase volume represents approximately $2.45 B in transactions.